Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Melanie Everitt to Biopsy

This is a "connection" page, showing publications Melanie Everitt has written about Biopsy.

 
Connection Strength
 
 
 
0.425
 
  1. Nakano SJ, Everitt MD. Beyond the biopsy: Is it time to change the gold standard for rejection diagnosis in clinical decision-making and scientific discovery? J Heart Lung Transplant. 2022 10; 41(10):1414-1416.
    View in: PubMed
    Score: 0.160
  2. Ware AL, Malmberg E, Delgado JC, Hammond ME, Miller DV, Stehlik J, Kfoury A, Revelo MP, Eckhauser A, Everitt MD. The use of circulating donor specific antibody to predict biopsy diagnosis of antibody-mediated rejection and to provide prognostic value after heart transplantation in children. J Heart Lung Transplant. 2016 Feb; 35(2):179-85.
    View in: PubMed
    Score: 0.099
  3. Everitt MD, Hammond ME, Snow GL, Stehlik J, Revelo MP, Miller DV, Kaza AK, Budge D, Alharethi R, Molina KM, Kfoury AG. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant. J Heart Lung Transplant. 2012 Jul; 31(7):686-93.
    View in: PubMed
    Score: 0.078
  4. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol. 2012 Nov-Dec; 21(6):445-54.
    View in: PubMed
    Score: 0.019
  5. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant. 2012 Jan; 31(1):46-51.
    View in: PubMed
    Score: 0.019
  6. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury AG. Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death? J Heart Lung Transplant. 2011 Feb; 30(2):144-50.
    View in: PubMed
    Score: 0.017
  7. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li DY, Li Y, Kfoury AG. Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc. 2010 Sep; 42(7):2687-92.
    View in: PubMed
    Score: 0.017
  8. Kfoury AG, Renlund DG, Snow GL, Stehlik J, Folsom JW, Fisher PW, Reid BB, Clayson SE, Gilbert EM, Everitt MD, Bader FM, Singhal AK, Hammond ME. A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation. J Heart Lung Transplant. 2009 Jan; 28(1):51-7.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)